Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
GlobeNewswire
· *$126.3 Million In Total Gross Proceeds from Warrant Distribution.
*
· *Over 1,900 Patients with Alzheimer’s..
· *$126.3 Million In Total Gross Proceeds from Warrant Distribution.
*
· *Over 1,900 Patients with Alzheimer’s..
MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Saputo Inc. (TSX:SAP) (we, Saputo or the Company) is proud to announce its Dairy..
Sydney, Australia (SPX) May 08, 2024
In a significant development in space logistics, Starfish Space and D-Orbit have..